Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Simone

Showing results (11-20 of 370) with videos related to

Pageof 37
Sort By:
European Urology|February 12, 2008
Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20Giuseppe Simone, Rocco Papalia, Michele Gallucci
Urology|July 8, 2017
Editorial CommentMariaconsiglia Ferriero, Tuderti Gabriele, Giuseppe Simone
BJU International|April 3, 2009
Re: Lymphovascular invasion predicts poor outcome of urothelial carcinoma of the renal pelvis after nephroureterectomyMariaconsiglia Ferriero, Giuseppe Simone, Michele Gallucci
Annals of Surgical Oncology|June 19, 2024
Continent or Incontinent Urinary Diversion: That is the QuestionGiuseppe Chiacchio, Riccardo Mastroianni, Giuseppe Simone
European Urology Focus|June 16, 2024
Reply to Wei He, Shuxiong Zeng, and Chuanliang Xu's Letter to the Editor re: Riccardo Mastroianni, Gabriele Tuderti, Mariaconsiglia Ferriero, et al. Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial. Eur Urol 2024;85:422-30Riccardo Mastroianni, Giuseppe Chiacchio, Giuseppe Simone
Translational Andrology and Urology|February 12, 2020
Are we really seeking for equivalence?-The virtue of the robot is in technologyAldo Brassetti, Riccardo Mastroianni, Giuseppe Simone
Urology|September 9, 2008
Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078)Giuseppe Simone, Costantino Leonardo, Michele Gallucci
Current Oncology (Toronto, Ont.)|May 15, 2023
Reply to May et al. The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on "Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892"Giuseppe Chiacchio, Aldo Brassetti, Giuseppe Simone
European Urology|March 11, 2025
Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)Rocco Simone Flammia, Costatino Leonardo, Giuseppe Simone
Journal of Endourology|January 14, 2015
Editorial comment for Pastore et alConstantino Leonardo, Cosimo De Nunzio, Giuseppe Simone
Pageof 37

Showing results (11-20 of 370) with videos related to

Sort By:
Pageof 37
European Urology|February 12, 2008
Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20Giuseppe Simone, Rocco Papalia, Michele Gallucci
Urology|July 8, 2017
Editorial CommentMariaconsiglia Ferriero, Tuderti Gabriele, Giuseppe Simone
BJU International|April 3, 2009
Re: Lymphovascular invasion predicts poor outcome of urothelial carcinoma of the renal pelvis after nephroureterectomyMariaconsiglia Ferriero, Giuseppe Simone, Michele Gallucci
Annals of Surgical Oncology|June 19, 2024
Continent or Incontinent Urinary Diversion: That is the QuestionGiuseppe Chiacchio, Riccardo Mastroianni, Giuseppe Simone
European Urology Focus|June 16, 2024
Reply to Wei He, Shuxiong Zeng, and Chuanliang Xu's Letter to the Editor re: Riccardo Mastroianni, Gabriele Tuderti, Mariaconsiglia Ferriero, et al. Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial. Eur Urol 2024;85:422-30Riccardo Mastroianni, Giuseppe Chiacchio, Giuseppe Simone
Translational Andrology and Urology|February 12, 2020
Are we really seeking for equivalence?-The virtue of the robot is in technologyAldo Brassetti, Riccardo Mastroianni, Giuseppe Simone
Urology|September 9, 2008
Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078)Giuseppe Simone, Costantino Leonardo, Michele Gallucci
Current Oncology (Toronto, Ont.)|May 15, 2023
Reply to May et al. The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on "Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892"Giuseppe Chiacchio, Aldo Brassetti, Giuseppe Simone
European Urology|March 11, 2025
Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)Rocco Simone Flammia, Costatino Leonardo, Giuseppe Simone
Journal of Endourology|January 14, 2015
Editorial comment for Pastore et alConstantino Leonardo, Cosimo De Nunzio, Giuseppe Simone
Pageof 37